Dr. Alfred Merz appointed Chief Executive Officer of ProBioGen Dr. Alfred Merz appointed Chief Executive Officer of ProBioGen Dr. Merz, who previously served as Chief Operating Officer (COO) and interim CEO, now assumes full leadership of the company Jim Gibson joins PacBio as chief financial officer Jim Gibson joins PacBio as chief financial officer Experienced finance leader to help drive company growth and innovation Beamex Group leadership team plan to deliver even greater value to customers Beamex Group leadership team plan to deliver even greater value to customers Beamex Group leadership team will deliver even greater value to customers with the appointment of two new experienced professionals in sales and operations Aenova appoints new Managing Director at Regensburg site Aenova appoints new Managing Director at Regensburg site Dr Nancy Thiels will lead the site with more than 350 employees and focus on the development and production of highly effective solid oral dosage forms Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy In this role, he will lead the company’s global Strategy initiatives and CPM functions, and he will be reporting directly to the CEO, serving as a member of the Global... iOnctura strengthens leadership with key executive appointments iOnctura strengthens leadership with key executive appointments Elizabeth Holt joins as chief business officer, and Dr Mark Velleca appointed board chair Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor and Laurence Reid joins as Non-Executive Director Cellevate strengthens management team with the appointment of Dr. Christel Fenge as Chief Technology Officer Cellevate strengthens management team with the appointment of Dr. Christel Fenge as Chief Technology Officer Cellevate AB is pleased to announce the appointment of Dr. Christel Fenge as Chief Technology Officer (CTO) and member of the management team Coriolis Pharma appoints Peter Sölkner to Board of Directors to support the company’s growth ambitions Coriolis Pharma appoints Peter Sölkner to Board of Directors to support the company’s growth ambitions With this appointment, Coriolis strengthens its Board of Directors with additional global expertise from the service sector for the pharmaceutical and biotech industry Aragen appoints Dr. Manjunath Ramarao as Chief Scientific Officer and Executive Vice President; Jayadeva Sajankila as Vice President and Head Aragen appoints Dr. Manjunath Ramarao as Chief Scientific Officer and Executive Vice President; Jayadeva Sajankila as Vice President and Head As the CSO, Dr. Ramarao will provide scientific leadership, nurture scientific talent, identify new and emerging capabilities and technologies and focus on green science... Ascend Advanced Therapies appoints John Chiminski as Chair & Karen Flynn as Independent Director Ascend Advanced Therapies appoints John Chiminski as Chair & Karen Flynn as Independent Director Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen Flynn as non-executive... Sygnature Discovery appoints new chief commercial officer Sygnature Discovery appoints new chief commercial officer Kieron Hall joins to lead commercial strategy and drive business growth Selig Group announces planned transition of chief executive officer Selig Group announces planned transition of chief executive officer Adam Sheridan to take over as CEO from July 1st Abzena appoints Taylor Boyd as chief business officer Abzena appoints Taylor Boyd as chief business officer New CBO to lead corporate development and strategic growth initiatives Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development Rentschler Biopharma SE, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, announced the promotion of Patrick Meyer, Ph.D., to... Seth Benson joins Nuclera as Chief Financial Officer Seth Benson joins Nuclera as Chief Financial Officer This appointment will drive commercial growth of eProtein Discovery and support strategic expansion